Mortality Reduction by Implantable Cardioverter-Defibrillators in High-Risk Patients With Heart Failure, Ischemic Heart Disease, and New-Onset Ventricular Arrhythmia: An Effectiveness Study
- 3 May 2005
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (9), 1474-1481
- https://doi.org/10.1016/j.jacc.2005.01.031
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Implantable Cardioverter Defibrillators in Primary and Secondary PreventionAnnals of Internal Medicine, 2003
- A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Sudden Cardiac DeathCirculation, 1998
- A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular ArrhythmiasNew England Journal of Medicine, 1997
- Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trialsThe Lancet, 1997
- Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular ArrhythmiaNew England Journal of Medicine, 1996
- A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular TachyarrhythmiasNew England Journal of Medicine, 1993
- The Cardiac Arrhythmia Suppression Trial (CAST)New England Journal of Medicine, 1989
- Sudden coronary death in the United States: 1980-1985.Circulation, 1989
- The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.Circulation, 1984